Huntleigh Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.51M Buy
5,935
+3,584
+152% +$835K 0.21% 105
2026
Q1
$575K Buy
2,351
+361
+18% +$84.1K 0.1% 162
2025
Q4
$412K Sell
1,990
-70
-3% -$13.8K 0.07% 184
2025
Q3
$382K Sell
2,060
-385
-16% -$66K 0.07% 196
2025
Q2
$374K Sell
2,445
-28
-1% -$4.3K 0.07% 185
2025
Q1
$410K Buy
2,473
+35
+1% +$5.48K 0.1% 155
2024
Q4
$353K Buy
+2,438
New +$378K 0.08% 172

Other funds holding JNJ

Huntleigh Advisors's JNJ Position: Q2 2026 in Review

Huntleigh Advisors increased its Johnson & Johnson (JNJ) stake by 152% in Q2 2026, buying an estimated $835K and bringing the position to 5,935 shares worth $1.51M. The position accounts for 0.21% of the portfolio, ranked #105.

Huntleigh Advisors first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Huntleigh Advisors held 5,935 shares of Johnson & Johnson worth $1.51M as of Q2 2026.
  • Huntleigh Advisors bought 3,584 Johnson & Johnson shares in Q2 2026, an estimated $835K.
  • Johnson & Johnson made up 0.21% of Huntleigh Advisors's portfolio in Q2 2026, its #105 holding.
  • Huntleigh Advisors first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Huntleigh Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.